CINACALCET

Generic: CINACALCET

Cipla USA Inc.Manufacturer
ORALRoute
CINACALCET HYDROCHLORIDEActive Substance
2018-03-08Original Approval

CINACALCET is FDA application ANDA208915, sponsored by CIPLA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2026-03-16
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class II2026-10-07
Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, I

Failed dissolution specifications

Class II2024-01-18
Cinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury,

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufactu

Class II2026-03-16
Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class II2026-06-29
Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Class II2024-10-10
Cinacalcet Tablets, 90 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-442-10, b) 90 Tablets per bottle, NDC: 16729-44

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable

Class II2024-10-09
Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India.,

CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Class II2025-11-14
Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independe

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable

Class II2025-11-14
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independe

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable

Class II2026-06-29
Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Top Reported Reactions

1
DEATH
439 reports
2
OFF LABEL USE
401 reports
3
DRUG INEFFECTIVE
374 reports
4
HYPOCALCAEMIA
273 reports
5
NAUSEA
229 reports
6
VOMITING
204 reports
7
HYPERCALCAEMIA
190 reports
8
DIARRHOEA
188 reports
9
ACUTE KIDNEY INJURY
152 reports
10
CALCIPHYLAXIS
141 reports